Sign in to fuzzto save your conversations, follow your research and come back anytime.
NOCIL
NOCIL
NSE
BSE
NSEBSESectorChemicals
171.80
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
NOCIL Ltd shows strong revenue and profit recovery in Q1 FY27, driven by higher volumes and better margins, though rising input and operating costs need monitoring.
Revenue grew from ₹336 Cr to ₹403 Cr from Q1 FY26 to Q1 FY27, showing strong top-line recovery.
Raw material costs surged from ₹195 Cr to ₹273 Cr from Q1 FY26 to Q1 FY27, pressuring input margins.
Net profit increased from ₹17 Cr to ₹28 Cr from Q1 FY26 to Q1 FY27, confirming bottom-line strength.
Other operating expenses rose from ₹88 Cr to ₹103 Cr from Q1 FY26 to Q1 FY27, requiring closer cost monitoring.
EBITDA margin expanded from 9.1% to 11.2% from Q1 FY26 to Q1 FY27, reflecting better pricing and efficiency.
Employee expenses climbed from ₹24 Cr to ₹27 Cr from Q1 FY26 to Q1 FY27, signaling higher workforce costs.
Finance cost remained at ₹0 from Q1 FY26 to Q1 FY27, keeping the balance sheet debt-free.
Profit before tax fluctuated from ₹23 Cr to ₹37 Cr from Q1 FY26 to Q1 FY27, showing earnings volatility despite recovery.
Sales volume increased from 133 units to 145 units from Q1 FY26 to Q1 FY27, indicating steady market demand.
